Synthetic organic

ilunocitinib.

ilunocitinib.

IM-12.

IM-12.

IM-12.

IM-12.

InformationImaradenant (AZD4635) Imaradenant (AZD4635, HTL1071) is an oral A2AR antagonist that binds to human A2AR with a Ki of 1.7 nM and with &gt: 30-fold selectivity over other adenosine receptors.TargetsA2AR (Cell-free) 1.7 nM(Ki)In vitroIn CHO

InformationImaradenant (AZD4635) Imaradenant (AZD4635, HTL1071) is an oral A2AR antagonist that binds to human A2AR with a Ki of 1.7 nM and with &gt: 30-fold selectivity over other adenosine receptors.TargetsA2AR (Cell-free) 1.7 nM(Ki)In vitroIn CHO

InformationImaradenant (AZD4635) Imaradenant (AZD4635, HTL1071) is an oral A2AR antagonist that binds to human A2AR with a Ki of 1.7 nM and with &gt: 30-fold selectivity over other adenosine receptors.TargetsA2AR (Cell-free) 1.7 nM(Ki)In vitroIn CHO

InformationImaradenant (AZD4635) Imaradenant (AZD4635, HTL1071) is an oral A2AR antagonist that binds to human A2AR with a Ki of 1.7 nM and with &gt: 30-fold selectivity over other adenosine receptors.TargetsA2AR (Cell-free) 1.7 nM(Ki)In vitroIn CHO

InformationImaradenant (AZD4635) Imaradenant (AZD4635, HTL1071) is an oral A2AR antagonist that binds to human A2AR with a Ki of 1.7 nM and with &gt: 30-fold selectivity over other adenosine receptors.TargetsA2AR (Cell-free) 1.7 nM(Ki)In vitroIn CHO

IMB-808.